Multimodal AI in Oral Cancer
Oral cancer presents significant diagnostic and prognostic challenges, often due to late-stage detection and tumour heterogeneity. Results indicate that multimodal AI models consistently outperform unimodal approaches in diagnostic accuracy, AUC and survival prediction.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Orforglipron improved physical and psychosocial functioning in adults…
In ATTAIN, phase 3, randomized, placebo-controlled trials, orforglipron treatment resulted in substantial weight reduction among people with obesity with or without type 2 diabetes. Across the ATTAIN-1 and ATTAIN-2 trials, orforglipron treatment was associated with substantial body weight reduction and improvements in patient-reported HRQoL, with consistent enhancements in physical functioning and heterogeneous effects on psychosocial functioning.ATTAIN-1: NCT05869903; ATTAIN-2:NCT05872620. © 2026 Published by Elsevier Inc. on behalf of Obesity Medicine Association.
Promising but preliminaryEfficacy and safety of stereotactic body radiotherapy combined with…
Stereotactic body radiotherapy (SBRT) may augment antitumor immunity when combined with immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC), but clinical studies span markedly different disease stages and treatment intents and have produced inconsistent comparative results. Although the primary DCR estimate was statistically significant, its sensitivity to individual studies and the low certainty of evidence preclude a firm efficacy conclusion.
Promising but preliminaryCEACAM5-Targeted Therapies in Solid Tumors
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) is an attractive therapeutic target because of its widespread overexpression in epithelial malignancies and its polarised, largely luminal expression in normal epithelium. Future patient selection should integrate CEACAM5 expression with target biology and therapeutic modality compatibility to identify patients likely to benefit and reduce ineffective treatment. © 2026 Ye et al.
Promising but preliminaryImpact of BMI on Ramadan fasting in individuals with type 2 diabetes mellitus
This study used data from the Diabetes and Ramadan (DaR) Global Survey, conducted via SurveyMonkey, to examine the associations between BMI and fasting-related outcomes among adults with T2DM in Muslim-majority countries. Individuals with T2DM in all BMI categories were able to fast safely during Ramadan, with no significant differences in fasting behavior or adverse events.